JNCCN 360 – Ovarian – Final Results From ARIEL4: Rucaparib vs Chemotherapy for BRCA-Mutated Ovarian Cancer

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn

Read the full article here

Source: jnccn360.org
Categories: General Medicine News
Tags:
Tweets with this article
Journal of the @NCCN
Final Results From ARIEL4: Rucaparib vs Chemotherapy for #BRCA-Mutated #OvarianCancer: https://t.co/qwJNfe1a5I #JNCCN360 #gyncsm https://t.co/276aRIkXHF

Related Articles